Interview with Ingo Raimon, General Manager, AbbVie Austria
You have had an extensive career at the company, since 1989. What does the company have to offer that has made you stay so long and dedicated? AbbVie is a…
Address: ‘EURO PLAZA Gebäude G, 5. Stock, Am Euro Platz 2 A-1120 Wien’,Austria
Tel: + 43 (0) 1/260 44-0
Web: http://www.msd.at/
IN 36 YEARS TO THE TOP
MSD has been in Austria for 36 years now. Accelerating the pace of innovation in research and development of innovative drugs is one of the most important tasks of MSD. We are investing large sums in competent staff and clinical research.
MSD Austria has 200 employees and reported 2009 sales of 156.3 million euros.
The guarantee of a reliable partnership with physicians and patients is one of the fundamental principles of MSD. MSD is committed to the company and all stakeholders in health care to be a competent, reliable and trustworthy partner.
Our employees act exactly in this sense: responsibly, with integrity and ethically.
As a research-based pharmaceutical company focused on developing innovative MSD patented medicines. The research focus is on the application areas of asthma and allergic rhinitis, cardiovascular disease and lipid metabolism, HIV, infection, endocrinology, Diabetiologie, oncology, and eye diseases.
You have had an extensive career at the company, since 1989. What does the company have to offer that has made you stay so long and dedicated? AbbVie is a…
Could you please provide an overview of your main scope of activities in Austria and the importance of healthcare and pharmaceuticals to Boston Consulting Group’s (BCG) business model and revenue?…
Prior to joining Kedrion you worked for CSL Behring for a number of years. What opportunities did you see for yourself in moving from there to Kedrion? The biggest opportunity…
LISAvienna celebrated its tenth anniversary in September. Could you briefly describe the core activities and organizational structure that has developed over the last decade? Austria has historically been quite strong…
Prior to founding Vela, you worked in a number of different positions with various companies such as Baxter and Octapharma. What opportunities did you see in founding your own company?…
Previously you worked for a pharmaceutical company, before moving to head up Eucodis Bioscience. What was your main motivation for switching from the pharmaceutical to the industrial biotech industry? The…
You have been the CEO of Herba Chemosan since 2002. What were the initial goals you set for yourself when you took up this position, and where do we find…
Can you give our readers a brief overview of Daiichi Sankyo in Austria as well as its market positioning and growth factors in 2012? Daiichi Sankyo Austria GmbH is the…
How does the Austrian affiliate fit within Quintiles’ global structure, and what is the scope of the company’s activities here? Quintiles Austria was established in 1996 and has grown from…
Could you give our readers a snapshot of the association and its role in the Austrian pharmaceutical context? FOPI is a small and specialized industry association that has a homogenous…
Almirall was opened through the acquisition of Hermal in 2007. What impact did that have on Almirall’s operations in central Europe, and where does Austria fit in Almirall’s picture today?…
2012 marks the twentieth anniversary of Polymun. Can you describe to our readers the origins of the company and how it compares to your expectations in 1992? Prior to founding…
See our Cookie Privacy Policy Here
